{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:05:27Z","timestamp":1789387527403,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunoglobulin A vasculitis (IgAV) is the most common childhood vasculitis, and involvement of multiple systems (gastrointestinal, joint, renal) may affect prognosis. Reliable biomarkers for predicting multi-system involvement are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the association between routine inflammation-related laboratory indicators and multi-system involvement in children with IgAV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective study included 657 children with IgAV diagnosed according to EULAR\/PRINTO\/PRES criteria. Patients were categorized into five mutually exclusive subgroups based on clinical phenotypes: skin only (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200975), gastrointestinal (GI,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200996), joint (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009158), kidney (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931), and multi-system (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009297) involvement. Laboratory parameters including white blood cell (WBC), neutrophils, platelets, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), albumin, and D-dimer were compared across groups. Generalized additive models (GAM) and ROC curve analysis were used to determine optimal cut-off values for age and disease duration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Multi-system involvement was the most common phenotype (45.2%). Compared with other subgroups, multi-system involvement patients showed significantly higher WBC (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.032), neutrophils (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), platelets (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002), NLR (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), PLR (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002), and D-dimer, while albumin was lowest (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Pairwise comparisons revealed that NLR and PLR elevations were most pronounced between multi-system and skin-only groups. GAM analysis identified 10 years as the optimal cut-off for onset age; children &amp;gt;10 years had significantly higher renal involvement rates (25.49% vs. 11.39%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and higher NLR (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019) than those \u226410 years. Multivariate logistic regression identified female sex (OR\u2009=\u20091.650,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.038), onset age &amp;gt;10 years (OR\u2009=\u20092.160,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.036), and longer disease duration (OR\u2009=\u20091.059,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.037) as independent risk factors for renal involvement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated inflammatory markers including WBC, neutrophils, platelets, NLR, PLR, and D-dimer, as well as decreased albumin, are associated with multi-system involvement in children with IgAV, with the most pronounced differences observed between multi-system and skin-only groups. Onset age &amp;gt;10 years is associated with increased renal involvement risk. These routine laboratory indicators, interpreted in conjunction with age and disease duration, may aid in early risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1921404","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:24:47Z","timestamp":1789385087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the inflammation indicators with multiple system involved of immunoglobulin A vasculitis in children"],"prefix":"10.3389","volume":"14","author":[{"given":"Hao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Dermatology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders","place":["Chongqing, China"]},{"name":"Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders","place":["Chongqing, China"]},{"name":"Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Children\u2019s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders","place":["Chongqing, China"]},{"name":"Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/jcm14093055","article-title":"Laboratory findings and clinical features in IgA vasculitis: identifying predictors of kidney involvement and disease relapse in pediatric patients","volume":"14","author":"Podraza","year":"2025","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-026-07382-8","article-title":"Biomarkers of kidney involvement in paediatric IgA vasculitis: a systematic review and meta-analysis","author":"Beltie","year":"2026","journal-title":"Pediatr Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3390\/biomedicines13010113","article-title":"The impact of infectious diseases on clinical characteristics and immunological correlations in pediatric Henoch-Sch\u00f6nlein purpura: a five-year retrospective study","volume":"13","author":"Opri\u021bescu","year":"2025","journal-title":"Biomedicines"},{"key":"B4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/JMDH.S499808","article-title":"Predictive laboratory markers for gastrointestinal complications in children with henoch-sch\u00f6nlein Purpura","volume":"18","author":"Guo","year":"2025","journal-title":"J Multidiscip Healthc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113063","DOI":"10.1016\/j.intimp.2024.113063","article-title":"Blood soluble CD89-IgA complex may be a potential biomarker for predicting multi-organ involvement, especially renal involvement in children with immunoglobulin A vasculitis","volume":"142","author":"Yu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.7499\/j.issn.1008-8830.2311151","article-title":"[Exploring the mechanism of IgA vasculitis pathogenesis through the interaction of thrombin and inflammatory factors using urinary proteomics]","volume":"26","author":"Liu","year":"2024","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for henoch-sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood wegener granulomatosis and childhood takayasu arteritis: ankara 2008. Part II: final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","article-title":"Iga nephropathy: an interesting autoimmune kidney disease","volume":"361","author":"Rajasekaran","year":"2021","journal-title":"Am J Med Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1007\/s00467-023-06023-8","article-title":"Clinical course and management of children with IgA vasculitis with nephritis","volume":"38","author":"Stone","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"771619","DOI":"10.3389\/fimmu.2021.771619","article-title":"Pathogenesis of IgA vasculitis: an up-to-date review","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"921864","DOI":"10.3389\/fimmu.2022.921864","article-title":"Iga vasculitis update: epidemiology, pathogenesis, and biomarkers","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/00099228251389785","article-title":"Analysis of clinical features and high-risk factors of gastrointestinal involvement in children with IgA vasculitis","volume":"65","author":"Cao","year":"2026","journal-title":"Clin Pediatr (Phila)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10067-018-4234-8","article-title":"Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis","volume":"38","author":"Kuret","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.17219\/acem\/138906","article-title":"The relationship between monocyte-to-lymphocyte ratio and the risk of gastrointestinal system involvement in children with IgA vasculitis: a preliminary report","volume":"30","author":"Yuan","year":"2021","journal-title":"Adv Clin Exp Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","article-title":"A test in context: d-dimer","volume":"70","author":"Weitz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1694532","DOI":"10.3389\/fimmu.2025.1694532","article-title":"Clinical review of adult henoch-sch\u00f6nlein purpura and analysis of predictors related to gastrointestinal involvement","volume":"16","author":"Guo","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/00325481.2020.1807161","article-title":"The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with henoch-sch\u00f6nlein Purpura","volume":"133","author":"Karada\u011f \u015e","year":"2021","journal-title":"Postgrad Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jpc.16516","article-title":"Clinical characteristics and risk factors of IgA vasculitis with intussusception and intestinal perforation","volume":"60","author":"Mu","year":"2024","journal-title":"J Paediatr Child Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e943912","DOI":"10.12659\/MSM.943912","article-title":"A review of IgA vasculitis (henoch-sch\u00f6nlein purpura) past, present, and future","volume":"30","author":"Parums","year":"2024","journal-title":"Med Sci Monit"},{"key":"B22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/21655979.2020.1865607","article-title":"Clinical relevance of neutrophil-to-lymphocyte ratio and mean platelet volume in pediatric henoch-schonlein purpura: a meta-analysis","volume":"12","author":"Li","year":"2021","journal-title":"Bioengineered"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1921404\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:24:48Z","timestamp":1789385088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1921404\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":22,"alternative-id":["10.3389\/fped.2026.1921404"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1921404","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"article-number":"1921404"}}